Cas:13580-86-4 4-Chloro-1-phthalazinamine manufacturer & supplier

We serve Chemical Name:4-Chloro-1-phthalazinamine CAS:13580-86-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Chloro-1-phthalazinamine

Chemical Name:4-Chloro-1-phthalazinamine
CAS.NO:13580-86-4
Synonyms:4-Chlorophthalazin-1-amine;4-Chloro-phthalazin-1-ylamine;1-Phthalazinamine, 4-chloro-;1-Phthalazinamine,4-chloro;1-Amino-4-chlor-phthalazin;1-Chlor-4-aminophthalazin;4-Chloro-1-phthalazinamine;4-Chloro-phthalazin-1-amine;1-amino-4-chlorophthalazine
Molecular Formula:C8H6ClN3
Molecular Weight:179.606
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:452.8±30.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.727
PSA:51.80000
Exact Mass:179.025024
LogP:1.91

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Chlorophthalazin-1-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-amino-4-chlorophthalazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-phthalazin-1-ylamine Use and application,4-Chloro-phthalazin-1-amine technical grade,usp/ep/jp grade.


Related News: He also mentioned that derivatives of these APIs and lot of other value-added APIs in the same range will also be manufactured at the new facility. NA2FB N-Glycan manufacturers Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. Defluoro N-Benzyl Paroxetine suppliers Such investment is by no means prohibitive and can reap substantial rewards that include shorter development timelines, lower costs, faster time to market, and game changing technological advantage for sustainable competitive edge. (s,s)-(+)-1,2-dicyclohexyl-1,2-ethanediol vendor & factory Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. ,Such investment is by no means prohibitive and can reap substantial rewards that include shorter development timelines, lower costs, faster time to market, and game changing technological advantage for sustainable competitive edge.